Table: Cyfuse Biomedical -2023 parent results

Cyfuse Biomedical KK

14/02/2024 06:30

Feb 14 (Reuters)- 
          Cyfuse Biomedical K.K. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended        Year to        NEXT   
              Dec 31, 2023     Dec 31, 2022    Dec 31, 2024      YEAR     
                 LATEST          YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales          61 mln          374 mln          605 mln                 
               (-83.7 pct)     (-47.1 pct)     (+891.4 pct)               
  Operating   loss 697 mln     loss 425 mln    loss 797 mln               
  Recurring   loss 586 mln     loss 433 mln    loss 724 mln               
  Net         loss 589 mln     loss 473 mln    loss 727 mln               
  EPS        loss 75.42 yen  loss 177.67 yen  loss 92.16 yen              
  Ann Div          NIL             NIL              NIL                   
  -Q2 Div          NIL             NIL              NIL                   
  -Q4 Div          NIL             NIL              NIL                   
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T